Posted on

Using Data Analytics to Impact COVID-19

Share

Using Data Analytics to Impact COVID-19

Healthcare leaders are rapidly developing data science and analytics tools to provide critical missing pieces to support COVID-19 efforts and pave the way for the future of technology. IQVIA has been on the forefront, having launched an open COVID-19 registry platform to advance understanding, symptom progression, treatment outcomes, and research.

On, June 2nd 2020, Nancy A. Dreyer, SVP and Chief Scientific Officer for Real World Evidence at IQVIA, discussed their registry platform, its quick evolution and its impact on COVID-19 efforts.